Items where authors include "Mistry, H."
Article
Abani, O., Abbas, A., Abbas, F. et al. (7724 more authors) (2025) Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Fatania, K., Frood, R. orcid.org/0000-0003-2681-9922, Mistry, H. et al. (4 more authors) (2025) Impact of intensity standardisation and ComBat batch size on clinical-radiomic prognostic models performance in a multi-centre study of patients with glioblastoma. European Radiology, 35. pp. 3354-3366. ISSN 0938-7994
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Mistry, H., Richardson, C.D., Higginbottom, A. orcid.org/0000-0002-3246-6695 et al. (7 more authors) (2024) Relationships of brain cholesterol and cholesterol biosynthetic enzymes to Alzheimer’s pathology and dementia in the CFAS population-derived neuropathology cohort. Neuroscience Research, 204. pp. 22-33. ISSN 0168-0102
Frood, R. orcid.org/0000-0003-2681-9922, Mercer, J., Brown, P. et al. (4 more authors) (2024) Training and external validation of pre-treatment FDG PET-CT-based models for outcome prediction in anal squamous cell carcinoma. European Radiology, 34 (5). pp. 3194-3204. ISSN 0938-7994
Fatania, K. orcid.org/0000-0003-2421-1083, Frood, R. orcid.org/0000-0003-2681-9922, Mistry, H. orcid.org/0000-0002-9683-1903 et al. (4 more authors) (2024) Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study. Cancers, 16 (7). 1301. ISSN 2072-6694
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Smith, T.A.D., West, C.M.L. orcid.org/0000-0002-0839-3449, Joseph, N. et al. (15 more authors) (2024) A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial. eBioMedicine, 101. 105032. ISSN 2352-3964
Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Slevin, F. orcid.org/0000-0002-7176-904X, Pan, S., Mistry, H. et al. (10 more authors) (2021) A Multicentre UK Study of Outcomes for Locally Advanced Sinonasal Squamous Cell Carcinoma Treated with Adjuvant or Definitive Intensity-modulated Radiotherapy. Clinical Oncology, 33 (10). e450-e461. ISSN 0936-6555
Salem, A., Mistry, H., Hatton, M. et al. (4 more authors) (2019) Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial. JAMA Oncology, 5 (3). e185335. ISSN 2374-2437
Conference or Workshop Item
Fatania, K., Frood, R., Mistry, H. et al. (4 more authors) (2024) P09.17.B Tumour size and overall survival in a cohort of patients with unifocal glioblastoma. A uni- and multivariable prognostic modelling and resampling study. In: 19th Meeting of the European Association of Neuro-Oncology (EANO 2024), 17-20 Oct 2024, Glasgow, United Kingdom.
Fatania, K., Frood, R., Mistry, H. et al. (4 more authors) (2024) P10.17.B Impact of intensity standardisation and combat batch size variation on combined clinical and radiomics prognostic models in patients with unifocal glioblastoma. In: 19th Meeting of the European Association of Neuro-Oncology, 17-20 Oct 2024, Glasgow, United Kingdom.
Portner, R., McWilliam, A., Zhong, J. et al. (16 more authors) (2022) Prostate Magnetic Resonance Imaging Delta-Radiomics during Image-Guided Conventional Fractionation and Stereotactic Ablative Radiotherapy. In: UNSPECIFIED.
Up a level